Sundeep Singh

Publication Details

• The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma.

  Singh S, Tang SJ, Sreenarasimhaiah J, Lara LF, Siddiqui A. Dig Dis Sci. 2011; 56 (8): 2491-6

  CA19-9 is a tumor marker for pancreatic cancer, cholangiocarcinoma, and other malignancies. However, its sensitivity and specificity is suboptimal in clinical practice, which we hypothesized limits its clinical utility.

  PubMedID: 21516323